A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia

BACKGROUND: Recent evidence points to an increased incidence of new-onset diabetes and a negative impact on glucose parameters with statin use. This study examined the safety of ezetimibe vs placebo for change from baseline to week 24 in HbA1c (primary endpoint), glycoalbumin, and fasting plasma glu...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Itori, Azuma, Kyoichi, Kakikawa, Taro, Oshima, Nobuyuki, Hanson, Mary E, Tershakovec, Andrew M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450465/
https://www.ncbi.nlm.nih.gov/pubmed/25929253
http://dx.doi.org/10.1186/s12944-015-0036-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450465/
https://www.ncbi.nlm.nih.gov/pubmed/25929253
http://dx.doi.org/10.1186/s12944-015-0036-z

Ejemplares similares